News

Desilux, a low-potency topical steroid, is the first drug formulated in the company’s patented “emollient (soothing) foam delivery vehicle”. The company says that the foam does not feel

In a report published in Clinical Cancer Research, the researchers say that the “Stat5” protein in the nucleus of prostate cancer cells was a significant predictor of which

According to the company, the market for stem cell technology is currently $500 million, and has been estimated to grow to $30 billion by the year 2010 due

The new European approval for the drug allows it to be used as a first-line treatment for severe, active and progressive rheumatoid arthritis, and can be used in

This newly identified set of molecules is called microRNA (miRNA), a collection of hundreds of snippets of non-coding RNA – typically no more than 22 nucleotides in length

The researchers studying a protein called km23, a protein that helps to direct protein cell traffic, have found that at least 42 percent of ovarian cancer patient tumor

The study (KEEPS) will explore whether beginning hormone therapy in women during the menopausal transition (ages 42 to 58) protects against atherosclerosis, the major cause of heart attacks.

Relenza is only available in an inhaled form, raising concerns that this method of delivery might not be ideal in an emergency situation, and could lead to the

To obtain the drug, patients must now register with the program, named iPLEDGE, and also must comply with a number of key requirements that include completing an informed